Kuvatris Therapeutics Inc (PXMD)
Kuvatris Therapeutics Inc (PXMD) is a common stock security traded on OTC Markets. The listed instrument is a common equity security, and it is classified in the healthcare sector and pharmaceuticals industry. In practical terms, this means the name refers to shares of an issuer associated with drug development and related pharmaceutical activity, rather than a fund, debt issue, or other security type. Kuvatris Therapeutics Inc (OTC-PXMD) should therefore be understood as an OTC Markets common stock listing tied to healthcare and pharmaceutical exposure within the public markets. The security_context is common equity.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-PXMD
|
—
|
—
|
—
|
—
|
—
|
—
|
Fair
|
—
|
—
|
—
|
0.0%
|
September 21, 2026
|
—
|
—
|
—
|
63.137 K
|
—
|
—
|
—
|
—
|
—
|
—
|